awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36862845-C0126E09-9BE1-4789-81B7-ED5F1309DFE5
Q36862845-C0126E09-9BE1-4789-81B7-ED5F1309DFE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36862845-C0126E09-9BE1-4789-81B7-ED5F1309DFE5
Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab
P2860
Q36862845-C0126E09-9BE1-4789-81B7-ED5F1309DFE5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36862845-C0126E09-9BE1-4789-81B7-ED5F1309DFE5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a00f38d23006e5a5a2ae1ec5981ac8199b0a0cc9
P2860
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.